90. Retinitis pigmentosa Clinical trials / Disease details

Clinical trials : 147 / Drugs : 176 - (DrugBank : 43) / Drug target genes : 49 - Drug target pathways : 110

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02018692 (ClinicalTrials.gov)	March 1, 2024	17/12/2013	The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa	The Effect of Oral Administration of 9-cis ß Carotene Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa	Retinitis Pigmentosa	Dietary Supplement: Alga Dunaliella Bardawil powder;Dietary Supplement: Placebo:Starch	Sheba Medical Center	NULL	Not yet recruiting	12 Years	18 Years	All	30	Phase 1/Phase 2	Israel
2	NCT01680510 (ClinicalTrials.gov)	September 2012	4/9/2012	The Effect of Oral Administration of 9-cis ß Carotene Rich Powder of the Alga Dunaliella Bardawil	The Effect of Oral Administration of 9-cis ß Carotene Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Patients With Retinitis Pigmentosa	Retinitis Pigmentosa	Dietary Supplement: Alga Dunaliella Bardawil;Other: Placebo (starch)	Sheba Medical Center	NULL	Active, not recruiting	18 Years	N/A	All	100	Phase 1/Phase 2	Israel
3	NCT01256697 (ClinicalTrials.gov)	August 2008	25/2/2010	The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa	The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella	Retinitis Pigmentosa	Dietary Supplement: Alga Dunaliella Bardawil;Dietary Supplement: Alga Dunaliella Bardawill;Other: Sugar pill	Sheba Medical Center	NULL	Completed	18 Years	N/A	Female	34	N/A	Israel